Eating more oily fish and wholegrain or wholemeal bread may help reduce a person’s risk of developing multiple sclerosis (MS), according to a new study that used data from a large U.K. database. The findings contribute to growing evidence showing that diet is “a potentially modifiable factor in MS onset and [also] progression,” the researchers…
Month: December 2025
Sanofi’s experimental MS therapy tolebrutinib suffers twin setbacks
Following negative Phase 3 trial results, Sanofi announced that it will not be pursuing approval of its experimental therapy tolebrutinib for primary progressive multiple sclerosis (PPMS). Meanwhile, a decision from the U.S. Food and Drug Administration (FDA) on tolebrutinib’s use in nonrelapsing secondary progressive MS (SPMS) is likely to be delayed again, the company said. Sanofi had…
The season of letting go of the curated self that MS helped build
There’s a kind of loneliness that comes from being almost understood — close enough for someone to recognize your outline, but not close enough to feel your weight. It’s a loneliness that doesn’t creep in all at once. It settles slowly, the way dust gathers on a shelf you thought you’d already wiped clean. For…
From our CEO
The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Connection, hope and agency: our Community Day with MS Queensland at the MS Australia Conference
The post Connection, hope and agency: our Community Day with MS Queensland at the MS Australia Conference appeared first on MS Australia. Source: www.msaustralia.org.au
Causes, Care and Cures – sharing cutting-edge research at MS Australia’s biennial conference, Brisbane
The post Causes, Care and Cures – sharing cutting-edge research at MS Australia’s biennial conference, Brisbane appeared first on MS Australia. Source: www.msaustralia.org.au
Your Voice Matters: What the 2025 Research and Advocacy Priorities Survey Reveals
The post Your Voice Matters: What the 2025 Research and Advocacy Priorities Survey Reveals appeared first on MS Australia. Source: www.msaustralia.org.au
Anti-Alemtuzumab antibodies
Tweet This post was created by Dr Tim Jamieson, a Health Economist at the Wolfson Institute of Population Health, Queen Mary University of London about his recent publication in the European Journal of Health Economics. The Health Economic and Policy Research Unit at QMUL has just published a piece of work in conjunction with Dr…
Chronic inflammation signals brain atrophy in children with MS: Study
Children with multiple sclerosis (MS) who have more paramagnetic rim lesions (PRLs) — areas of chronic active inflammation seen on MRI scans — tend to lose more brain volume over time, a new study found. These lesions were common in pediatric MS, a rare form of the disease that develops during childhood or adolescence, appearing…
The Reality of Living with SPMS
Hello all, and long time, no speak! I feel rubbish that I haven’t blogged in months but, at the same … The post The Reality of Living with SPMS appeared first on . SPMS and My Body Image Living with a Progressive Chronic illness…. New Meds, New House, New Feelings about My MS… Source: trippingthroughtreacle.com